This article provides a critical guide for researchers and drug development professionals on benchmarking catalyst lifetime, a pivotal yet often overlooked metric in pharmaceutical process chemistry.
This article provides a comprehensive framework for researchers, scientists, and drug development professionals to identify, troubleshoot, and resolve data inconsistencies in catalytic metrics (e.g., kcat, Km, Vmax).
This article provides a comprehensive guide for researchers and drug development professionals on addressing the critical challenge of computational cost in catalyst screening.
This article provides a comprehensive guide for researchers, scientists, and drug development professionals on tackling the high computational expense of modern catalyst discovery workflows.
This comprehensive review analyzes the complex challenge of competitive Hydrogen Evolution Reactions (HER) in non-aqueous electrochemical systems, a critical barrier for energy storage and conversion technologies.
This comprehensive review addresses the critical challenge of catalyst sintering and surface area reduction, a major deactivation mechanism impacting catalytic efficiency in biomedical and pharmaceutical processes.
This article provides a targeted guide for drug development researchers on catalyst poisoning, a critical failure mode in synthetic chemistry.
This article provides a comprehensive framework for understanding and addressing catalyst deactivation in pharmaceutical performance testing.
Hydrogen-bond catalysis (HBC) offers a powerful, often biomimetic approach to enantioselective synthesis, but its practical application is frequently hindered by catalyst deactivation.
Single-atom catalysts (SACs) hold immense promise for revolutionizing catalytic processes in drug synthesis, biosensing, and therapeutic applications.